Most Popular
![[Exclusive] Hyundai Mobis eyes closer ties with BYD](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/25/20241125050044_0.jpg&u=)
-
6
[Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance
![[Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/25/20241125050072_0.jpg&u=)
-
7
Why S. Korean refiners are reluctant to import US oil despite Trump’s energy push
-
8
Agency says Jung Woo-sung unsure on awards attendance after lovechild revelations
-
9
Prosecutors seek 5-year prison term for Samsung chief in merger retrial
-
10
UN talks on plastic pollution treaty begin with grim outlook
![[Herald Review] 'Gangnam B-Side' combines social realism with masterful suspense, performance](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/11/25/20241125050072_0.jpg&u=)
Boyrung Biopharma launches 5-year cord blood research project
By Korea HeraldPublished : July 15, 2016 - 10:58
[THE INVESTOR] Boryung Biopharma is to research immune cell treatments using umbilical cord blood in collaboration with Seoul St. Mary’s Hospital.
The company said on July 14, that it signed an agreement with the hospital to conduct research in a 5-year project aimed at developing a range of treatments for immune cells.
By Choi He-suk (cheesuk@heraldcorp.com)
The company said on July 14, that it signed an agreement with the hospital to conduct research in a 5-year project aimed at developing a range of treatments for immune cells.
By Choi He-suk (cheesuk@heraldcorp.com)
-
Articles by Korea Herald
